create a website

Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
In: CESifo Working Paper Series.
RePEc:ces:ceswps:_9704.

Full description at Econpapers || Download paper

Cited: 1

Citations received by this document

Cites: 82

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Why higher copayments for opioids did not reduce use among Medicare beneficiaries. (2024). Kaestner, Robert ; Joyce, Geoffrey ; Zhou, BO.
    In: Health Economics.
    RePEc:wly:hlthec:v:33:y:2024:i:3:p:466-481.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. ———. 2011. “Further simulation evidence on the performance of the Poisson pseudo-maximum likelihood estimator.” Economics Letters 112 (2):220–222.
    Paper not yet in RePEc: Add citation now
  2. ———. 2017. “Mortality and morbidity in the 21st century.” Brookings Papers on Economic Activity 2017:397–476.
    Paper not yet in RePEc: Add citation now
  3. ———. 2018. “Deaths of Despair or Drug Problems?” Tech. Rep. w24188, National Bureau of Economic Research.
    Paper not yet in RePEc: Add citation now
  4. ———. 2018. “Deaths of despair redux: a response to Christopher Ruhm.” Tech. rep., National Bureau of Economic Research.
    Paper not yet in RePEc: Add citation now
  5. ———. 2019. “Drivers of the fatal drug epidemic.” Journal of Health Economics 64:25–42.
    Paper not yet in RePEc: Add citation now
  6. ———. 2020. “National drug control strategy.” Report, Executive Office of the President of the United States.
    Paper not yet in RePEc: Add citation now
  7. ———. 2020. “U.S. Opioid Dispensing Rate Maps.” URL https://www.cdc.gov/drugoverdose/ maps/rxrate-maps.html.
    Paper not yet in RePEc: Add citation now
  8. ———. 2020. Deaths of Despair and the Future of Capitalism. Princeton University Press.
    Paper not yet in RePEc: Add citation now
  9. ———. 2021. “Provisional drug overdose death counts.” URL https://www.cdc.gov/nchs/nvss/ vsrr/drug-overdose-data.htm.
    Paper not yet in RePEc: Add citation now

  10. Alpert, Abby, David Powell, and Rosalie Liccardo Pacula. 2018. “Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterrent opioids.” American Economic Journal: Economic Policy 10 (4):1–35.

  11. Alpert, Abby, Sarah Dykstra, and Mireille Jacobson. 2020. “How do prescription drug monitoring programs reduce opioid prescribing? The role of hassle costs versus information.” NBER Working Paper No. 27584, National Bureau of Economic Research.

  12. Alpert, Abby, William Evans, Ethan Lieber, and David Powell. 2019. “Origins of the Opioid Crisis and Its Enduring Impacts.” NBER Working Paper No. 26500, National Bureau of Economic Research.

  13. Brady, Joanne, Hannah Wunsch, Charles DiMaggio, Barbara Lang, James Giglio, and Guohua Li. 2014. “Prescription drug monitoring and dispensing of prescription opioids.” Public Health Reports 129 (2):139–147.
    Paper not yet in RePEc: Add citation now
  14. Brummett, Chad, Jennifer Waljee, Jenna Goesling, Stephanie Moser, Paul Lin, Michael Englesbe, Amy Bohnert, Sachin Kheterpal, and Brahmajee Nallamothu. 2017. “New persistent opioid use after minor and major surgical procedures in US adults.” JAMA Surgery 152 (6):e170504–e170504.
    Paper not yet in RePEc: Add citation now

  15. Buchmueller, Thomas and Colleen Carey. 2018. “The effect of prescription drug monitoring programs on opioid utilization in Medicare.” American Economic Journal: Economic Policy 10 (1):77–112.

  16. Buchmueller, Thomas, Colleen Carey, and Giacomo Meille. 2020. “How well do doctors know their patients ? Evidence from a mandatory access prescription drug monitoring program.” Health Economics 29 (9):957–974.

  17. Callaway, Brantly and Pedro Sant’Anna. 2020. “Difference-in-differences with multiple time periods.” Journal of Econometrics .

  18. Case, Anne and Angus Deaton. 2015. “Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.” Proceedings of the National Academy of Sciences 112 (49):15078–15083.

  19. Caulkins, Jonathan. 2001. “Drug prices and emergency department mentions for cocaine and heroin.” American Journal of Public Health 91 (9):1446–1448.

  20. CDC. 2016. “CDC Guideline for Prescribing Opioids for Chronic Pain - Factsheet.” Tech. rep., Centers for Disease Control and Prevention.
    Paper not yet in RePEc: Add citation now

  21. Ciani, Emanuele and Paul Fisher. 2019. “Dif-in-dif estimators of multiplicative treatment effects.” Journal of Econometric Methods 8 (1).

  22. Cicero, Theodore and Matthew Ellis. 2015. “Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: Lessons learned from OxyContin.” JAMA Psychiatry 72 (5):424–430.
    Paper not yet in RePEc: Add citation now
  23. Cicero, Theodore, Matthew Ellis, Hilary Surratt, and Steven Kurtz. 2014. “The changing face of heroin use in the United States: A retrospective analysis of the past 50 years.” JAMA Psychiatry 71 (7):821–826.
    Paper not yet in RePEc: Add citation now

  24. Currie, Janet and Hannes Schwandt. 2020. “The opioid epidemic was not caused by economic distress but by factors that could be more rapidly addressed.” NBER Working Paper No. 27544, National Bureau of Economic Research.

  25. Davis, Corey, Matthew Pierce, and Nabarun Dasgupta. 2014. “Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011.” American Journal of Public Health 104 (8):1389–1395.

  26. De Chaisemartin, Clément and Xavier d’Haultfoeuille. 2020. “Two-way fixed effects estimators with heterogeneous treatment effects.” American Economic Review 110 (9):2964–2996.

  27. DiNardo, John and Thomas Lemieux. 2001. “Alcohol, marijuana, and American youth: the unintended consequences of government regulation.” Journal of Health Economics 20 (6):991–1010.

  28. Dobkin, Carlos and Nancy Nicosia. 2009. “The war on drugs: methamphetamine, public health, and crime.” American Economic Review 99 (1):324–349.

  29. Dobkin, Carlos, Nancy Nicosia, and Matthew Weinberg. 2014. “Are supply-side drug control efforts effective ? Evaluating OTC regulations targeting methamphetamine precursors.” Journal of Public Economics 120:48–61.

  30. Dowell, Deborah, Tamara Haegerich, and Roger Chou. 2016. “CDC guideline for prescribing opioids for chronic pain - United States, 2016.” MMWR Recommendations and Reports 65 (1):1–49.
    Paper not yet in RePEc: Add citation now
  31. Evans, Mary, Matthew Harris, and Lawrence Kessler. 2020. “The hazards of unwinding the prescription opioid epidemic: implications for child abuse and neglect.” Research Paper No. 3582060, Claremont McKenna College Robert Day School of Economics and Finance.
    Paper not yet in RePEc: Add citation now

  32. Evans, William, Ethan Lieber, and Patrick Power. 2019. “How the reformulation of OxyContin ignited the heroin epidemic.” Review of Economics and Statistics 101 (1):1–15.

  33. Fally, Thibault. 2015. “Structural gravity and fixed effects.” Journal of International Economics 97 (1):76– 85.

  34. Fields, Howard. 2011. “The Doctor’s Dilemma: opiate analgesics and chronic pain.” Neuron 69 (4):591–594.
    Paper not yet in RePEc: Add citation now
  35. Fisher, Ronald. 1935. The Design of Experiments. Oliver and Boyd, Edinburgh (UK).
    Paper not yet in RePEc: Add citation now
  36. Gihleb, Rania, Osea Giuntella, and Ning Zhang. 2019. “The effects of mandatory Prescription Drug Monitoring Programs on foster care admissions.” Journal of Human Resources .
    Paper not yet in RePEc: Add citation now

  37. Goodman-Bacon, Andrew. 2021. “Difference-in-differences with variation in treatment timing.” Journal of Econometrics .

  38. Grecu, Anca, Dhaval Dave, and Henry Saffer. 2019. “Mandatory access Prescription Drug Monitoring Programs and prescription drug abuse.” Journal of Policy Analysis and Management 38 (1):181–209.

  39. Griffin, Beth Ann, Megan Schuler, Elizabeth Stuart, Stephen Patrick, Elizabeth McNeer, Rosanna Smart, David Powell, Bradley Stein, Terry Schell, and Rosalie Liccardo Pacula. 2020. “Variation in performance of commonly used statistical methods for estimating effectiveness of state-level opioid policies on opioidrelated mortality.” Working Paper 27029, National Bureau of Economic Research.
    Paper not yet in RePEc: Add citation now

  40. Grossmann, Volker and Holger Strulik. 2021. “Illicit drugs and the decline of the middle class.” Journal of Economic Behavior & Organization 183:718–743.

  41. Haegerich, Tamara, Leonard Paulozzi, Brian Manns, and Christopher Jones. 2014. “What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. ” Drug and Alcohol Dependence 145:34–47.
    Paper not yet in RePEc: Add citation now
  42. Harrell, A. V. 1997. “The validity of self-reported drug use data: the accuracy of responses on confidential self-administered answered sheets.” NIDA Research Monograph 167:37–58.
    Paper not yet in RePEc: Add citation now
  43. Hess, Simon. 2017. “Randomization inference with Stata: A guide and software.” The Stata Journal 17 (3):630–651.
    Paper not yet in RePEc: Add citation now
  44. Higham, Scott, Sari Horwitz, and Steven Rich. 2019. “76 billion opioid pills: Newly released federal data unmasks the epidemic.” Washington Post .
    Paper not yet in RePEc: Add citation now
  45. Horwitz, Jill, Corey Davis, Lynn McClelland, Rebecca Fordon, and Ellen Meara. 2018. “The problem of data quality in analyses of opioid regulation: The case of Prescription Drug Monitoring Programs.” NBER Working Paper 24947, National Bureau of Economic Research.
    Paper not yet in RePEc: Add citation now
  46. Jones, Christopher, Margaret Warner, Holly Hedegaard, and Wilson Compton. 2019. “Data quality considerations when using county-level opioid overdose death rates to inform policy and practice.” Drug and Alcohol Dependence 204:107549.
    Paper not yet in RePEc: Add citation now
  47. Jones, Jermaine, Shanthi Mogali, and Sandra Comer. 2012. “Polydrug abuse: a review of opioid and benzodiazepine combination use.” Drug and Alcohol Dependence 125 (1-2):8–18.
    Paper not yet in RePEc: Add citation now

  48. Kim, Bokyung. 2021. “Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences.” Journal of Health Economics 75:102408.

  49. Krueger, Alan. 2017. “Where have all the workers gone? An inquiry into the decline of the US labor force participation rate.” Brookings Papers on Economic Activity 2017 (2):1–88.

  50. Martin, Bradley, Ming-Yu Fan, Mark Edlund, Andrea DeVries, Jennifer Brennan Braden, and Mark Sullivan. 2011. “Long-term chronic opioid therapy discontinuation rates from the TROUP study.” Journal of General Internal Medicine 26 (12):1450–1457.
    Paper not yet in RePEc: Add citation now
  51. Mauri, Amanda I., Tarlise N. Townsend, and Rebecca L. Haffajee. 2020. “The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.” The Milbank Quarterly 98 (1):57–105.
    Paper not yet in RePEc: Add citation now
  52. McClellan, Chandler. 2019. “Disparities in opioid related mortality between United States counties from 2000 to 2014.” Drug and Alcohol Dependence 199:151–158.
    Paper not yet in RePEc: Add citation now
  53. Meara, Ellen and Jonathan Skinner. 2015. “Losing ground at midlife in America.” Proceedings of the National Academy of Sciences 112 (49):15006–15007.
    Paper not yet in RePEc: Add citation now
  54. Meara, Ellen, Jill Horwitz, Wilson Powell, Lynn McClelland, Weiping Zhou, James O’Malley, and Nancy Morden. 2016. “State legal restrictions and prescription-opioid use among disabled adults.” New England Journal of Medicine 375 (1):44–53.
    Paper not yet in RePEc: Add citation now

  55. Meinhofer, Angélica. 2018. “Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse.” American Journal of Health Economics 4 (4):504–526.

  56. Mora, Frank. 1996. “Victims of the balloon effect: Drug trafficking and US policy in Brazil and the Southern Cone of Latin America.” The Journal of Social, Political, and Economic Studies 21 (2):115–140.
    Paper not yet in RePEc: Add citation now
  57. Muhuri, Pradip, Joseph Gfroerer, and Christine Davies. 2013. “Associations of nonmedical pain reliever use and initiation of heroin use in the United States.” CBHSQ Data Review 1:17.
    Paper not yet in RePEc: Add citation now

  58. Murphy, Kevin, Michael Grossman, and Gary Becker. 2006. “The market for illegal goods: The case of drugs.” Journal of Political Economy 114:38–60.

  59. Office of National Drug Control Policy. 2019. “FY2020 budget and performance summary.” Report, Executive Office of the President of the United States.
    Paper not yet in RePEc: Add citation now
  60. Oliva, Elizabeth M., Thomas Bowe, Ajay Manhapra, Stefan Kertesz, Jennifer M. Hah, Patricia Henderson, Amy Robinson, Meenah Paik, Friedhelm Sandbrink, Adam J. Gordon, and et al. 2020. “Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation.” BMJ 368:m283.
    Paper not yet in RePEc: Add citation now
  61. Pardo, Bryce. 2017. “Do more robust Prescription Drug Monitoring Programs reduce prescription opioid overdose?” Addiction 112 (10):1773–1783.
    Paper not yet in RePEc: Add citation now
  62. Reuter, Peter and Mark Kleiman. 1986. “Risks and prices: An economic analysis of drug enforcement.” Crime and Justice 7:289–340.
    Paper not yet in RePEc: Add citation now
  63. Rose, Adam, Dana Bernson, Kenneth Kwan Ho Chui, Thomas Land, Alexander Walley, Marc LaRochelle, Bradley Stein, and Thomas Stopka. 2018. “Potentially inappropriate opioid prescribing, overdose, and mortality in Massachusetts, 2011-2015.” Journal of General Internal Medicine 33 (9):1512–1519.
    Paper not yet in RePEc: Add citation now
  64. Rudd, Rose, Noah Aleshire, Jon Zibbell, and Matthew Gladden. 2016. “Increases in Drug and Opioid Overdose Deaths - United States, 2000–2014.” MMWR Recommendations and Reports 64 (50):1378– 1382.
    Paper not yet in RePEc: Add citation now

  65. Ruhm, Christopher. 2016. “Taking the measure of a fatal drug epidemic.” Tech. Rep. 22504, National Bureau of Economic Research.

  66. Sacks, Daniel W., Alex Hollingsworth, Thuy Nguyen, and Kosali Simon. 2021. “Can policy affect initiation of addictive substance use? Evidence from opioid prescribing.” Journal of Health Economics 76:102397.

  67. Sant’Anna, Pedro and Jun Zhao. 2020. “Doubly robust difference-in-differences estimators.” Journal of Econometrics 219 (1):101–122.

  68. Santos Silva, Joao and Silvana Tenreyro. 2006. “The log of gravity.” Review of Economics and Statistics 88 (4):641–658.

  69. Schnell, Molly and Janet Currie. 2018. “Addressing the opioid epidemic: is there a role for physician education?” American Journal of Health Economics 4 (3):383–410.

  70. Schnell, Molly. 2017. “Physician behavior in the presence of a secondary market: The case of prescription opioids.” Mimeo, Princeton University.
    Paper not yet in RePEc: Add citation now
  71. Schuler, Megan, Sara Heins, Rosanna Smart, Beth Ann Griffin, David Powell, Elizabeth Stuart, Bryce Pardo, Sierra Smucker, Stephen Patrick, Rosalie Liccardo Pacula, and Bradley Stein. 2020. “The State of the science in opioid policy research.” Drug and Alcohol Dependence 214:108137.
    Paper not yet in RePEc: Add citation now
  72. Simoni-Wastila, Linda and Jingjing Qian. 2012. “Influence of prescription monitoring programs on analgesic utilization by an insured retiree population.” Pharmacoepidemiology and Drug Safety 21 (12):1261–1268.
    Paper not yet in RePEc: Add citation now
  73. Smithson, Michael, Michael McFadden, and Sue-Ellen Mwesigye. 2005. “Impact of Federal drug law enforcement on the supply of heroin in Australia.” Addiction 100 (8):1110–1120.
    Paper not yet in RePEc: Add citation now

  74. Strulik, Holger. 2021. “From pain patient to junkie: An economic theory of painkiller consumption and its impact on wellbeing and longevity.” Journal of Health Economics 76:102432.

  75. Sun, Eric, Anjali Dixit, Keith Humphreys, Beth Darnall, Laurence Baker, and Sean Mackey. 2017. “Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.” BMJ 356:1–7.
    Paper not yet in RePEc: Add citation now
  76. U.S. Department of Health & Human Services. 2016. “The opioid epidemic - By the numbers.” Technical report, U.S. Department of Health & Human Services.
    Paper not yet in RePEc: Add citation now
  77. Volkow, Nora and Thomas McLellan. 2016. “Opioid abuse in chronic pain - Misconceptions and mitigation strategies.” New England Journal of Medicine 374 (13):1253–1263.
    Paper not yet in RePEc: Add citation now
  78. Volkow, Nora, Thomas Frieden, Pamela Hyde, and Stephen Cha. 2014. “Medication-assisted therapies -Tackling the opioid-overdose epidemic.” New England Journal of Medicine 370 (22):2063–2066.
    Paper not yet in RePEc: Add citation now
  79. Volkow, Nora. 2018. “Medications for opioid use disorder: bridging the gap in care.” Lancet 391:285–287.
    Paper not yet in RePEc: Add citation now

  80. Wooldridge, Jeffrey. 1999. “Distribution-free estimation of some nonlinear panel data models.” Journal of Econometrics 90 (1):77–97.

  81. Young, Alwyn. 2019. “Channeling fisher: Randomization tests and the statistical insignificance of seemingly significant experimental results.” The Quarterly Journal of Economics 134 (2):557–598.

  82. Zhu, Wenjia, Michael Chernew, Tisamarie Sherry, and Nicole Maestas. 2019. “Initial opioid prescriptions among U.S. commercially insured patients, 2012–2017.” New England Journal of Medicine 380 (11):1043–1052. For Online Publication Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare. (2023). Simon, Kosali ; Maclean, Johanna ; Cantor, Jonathan H ; Taylor, Erin ; Agniel, Denis.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:31884.

    Full description at Econpapers || Download paper

  2. Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior. (2022). Grooms, Jevay ; Ellyson, Alice M ; Ortega, Alberto.
    In: Health Economics.
    RePEc:wly:hlthec:v:31:y:2022:i:2:p:297-341.

    Full description at Econpapers || Download paper

  3. Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21. (2022). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29719.

    Full description at Econpapers || Download paper

  4. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp15221.

    Full description at Econpapers || Download paper

  5. Opioids and the Labor Market. (2022). Schweitzer, Mark ; Fee, Kyle ; Aliprantis, Dionissi.
    In: Working Papers.
    RePEc:fip:fedcwq:180702.

    Full description at Econpapers || Download paper

  6. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_9704.

    Full description at Econpapers || Download paper

  7. Are prescription drug monitoring laws effective for all? Evidence from administrative data. (2022). Gupta, Sumedha ; al Achkar, Morhaf ; Ray, Bradley.
    In: Contemporary Economic Policy.
    RePEc:bla:coecpo:v:40:y:2022:i:1:p:28-47.

    Full description at Econpapers || Download paper

  8. Information Avoidance and Celebrity Exposure: The Effect of Magic Johnson on AIDS Diagnoses and Mortality in the U.S.. (2021). Martin, Joshua ; Rodriguez, Zachary ; Cardazzi, Alexander.
    In: Working Papers.
    RePEc:wvu:wpaper:21-04.

    Full description at Econpapers || Download paper

  9. Prescription drug monitoring programs, opioid abuse, and crime. (2021). Horn, Brady ; Deza, Monica ; Dave, Dhaval.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:87:y:2021:i:3:p:808-848.

    Full description at Econpapers || Download paper

  10. The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity. (2021). Wang, Lucy Xiaolu.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:9:p:2026-2046.

    Full description at Econpapers || Download paper

  11. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2021). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29596.

    Full description at Econpapers || Download paper

  12. Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation. (2021). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29574.

    Full description at Econpapers || Download paper

  13. Illicit Drugs and the Decline of the Middle Class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp14035.

    Full description at Econpapers || Download paper

  14. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
    In: Finance and Economics Discussion Series.
    RePEc:fip:fedgfe:2021-25.

    Full description at Econpapers || Download paper

  15. Thinking outside the box: The cross-border effect of tax cuts on R&D. (2021). Schwab, Thomas ; Todtenhaupt, Maximilian.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:204:y:2021:i:c:s0047272721001729.

    Full description at Econpapers || Download paper

  16. Is the rise in illicit opioids affecting labor supply and disability claiming rates?. (2021). Powell, David ; Park, Sujeong.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000151.

    Full description at Econpapers || Download paper

  17. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. (2021). Hollingsworth, Alex ; Nguyen, Thuy ; Simon, Kosali ; Sacks, Daniel W.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629620310432.

    Full description at Econpapers || Download paper

  18. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences. (2021). Kim, Bo Kyung.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:75:y:2021:i:c:s0167629620310547.

    Full description at Econpapers || Download paper

  19. Illicit drugs and the decline of the middle class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:183:y:2021:i:c:p:718-743.

    Full description at Econpapers || Download paper

  20. Designing interagency responses to wicked problems: Creating a common, cross-agency understanding. (2021). Sydelko, Pamela ; Midgley, Gerald ; Espinosa, Angela.
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:294:y:2021:i:1:p:250-263.

    Full description at Econpapers || Download paper

  21. Can electronic prescribing mandates reduce opioid-related overdoses?. (2021). Powell, David ; Abouk, Rahi.
    In: Economics & Human Biology.
    RePEc:eee:ehbiol:v:42:y:2021:i:c:s1570677x21000241.

    Full description at Econpapers || Download paper

  22. The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime. (2021). Giua, Ludovica ; Ludovica, Giua ; Claudio, Deiana.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:21:y:2021:i:2:p:751-792:n:11.

    Full description at Econpapers || Download paper

  23. Breaking the Crystal Methamphetamine Economy: Illegal Drugs, Supply‐side Interventions and Crime Responses. (2021). d'Este, Rocco.
    In: Economica.
    RePEc:bla:econom:v:88:y:2021:i:349:p:208-233.

    Full description at Econpapers || Download paper

  24. When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic. (2021). Glaeser, Edward L ; Cutler, David M.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:35:y:2021:i:4:p:171-96.

    Full description at Econpapers || Download paper

  25. How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program. (2020). Buchmueller, Thomas C ; Meille, Giacomo ; Carey, Colleen M.
    In: Health Economics.
    RePEc:wly:hlthec:v:29:y:2020:i:9:p:957-974.

    Full description at Econpapers || Download paper

  26. Drugs on the Web, Crime in the Streets - The Impact of Dark Web Marketplaces on Street Crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucn:wpaper:202025.

    Full description at Econpapers || Download paper

  27. Drugs on the Web, Crime in the Streets. The impact of Dark Web marketplaces on street crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucd:wpaper:202009.

    Full description at Econpapers || Download paper

  28. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27804.

    Full description at Econpapers || Download paper

  29. Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws. (2020). Simon, Kosali ; Gupta, Sumedha ; Nguyen, Thuy D ; Freeman, Patricia R.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27520.

    Full description at Econpapers || Download paper

  30. Three Myths about Federal Regulation. (2020). Mulligan, Casey ; McLaughlin, Patrick A.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27233.

    Full description at Econpapers || Download paper

  31. Paid sick-leave and physical mobility: Evidence from the United States during a pandemic. (2020). Simon, Kosali ; Pesko, Michael ; Maclean, Johanna ; Andersen, Martin.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27138.

    Full description at Econpapers || Download paper

  32. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26988.

    Full description at Econpapers || Download paper

  33. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26812.

    Full description at Econpapers || Download paper

  34. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2020-10.

    Full description at Econpapers || Download paper

  35. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp13395.

    Full description at Econpapers || Download paper

  36. Retail Pharmacies and Drug Diversion during the Opioid Epidemic. (2020). Zhang, Xuan ; Janssen, Aljoscha.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:1373.

    Full description at Econpapers || Download paper

  37. The relationship of opioid prescriptions and the educational performance of children. (2020). Ozturk, Orgul ; Gordanier, John M ; Cotti, Chad D.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620306250.

    Full description at Econpapers || Download paper

  38. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

  39. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. (2020). Powell, David ; Pacula, Rosalie ; Taylor, Erin.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303029.

    Full description at Econpapers || Download paper

  40. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey B.
    In: Working Papers.
    RePEc:bfi:wpaper:2020-10.

    Full description at Econpapers || Download paper

  41. Shackling the Identification Police?. (2019). Ruhm, Christopher.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:85:y:2019:i:4:p:1016-1026.

    Full description at Econpapers || Download paper

  42. Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision. (2019). Wettstein, Gal.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:5:p:666-677.

    Full description at Econpapers || Download paper

  43. Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin. (2019). Beheshti, David.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:12:p:1449-1461.

    Full description at Econpapers || Download paper

  44. How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs. (2019). Simon, Kosali ; Bradford, W. David ; Nguyen, Thuy D.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26356.

    Full description at Econpapers || Download paper

  45. Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing. (2019). Simon, Kosali ; Hollingsworth, Alex ; Nguyen, Thuy D ; Sacks, Daniel W.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25974.

    Full description at Econpapers || Download paper

  46. A novel supply-side measure to combat abuse of addictive prescription drugs. (2019). Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2019_11.

    Full description at Econpapers || Download paper

  47. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Bockerman, Petri ; Saxell, Tanja.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12275.

    Full description at Econpapers || Download paper

  48. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Saxell, Tanja ; Bockerman, Petri.
    In: Working Papers.
    RePEc:fer:wpaper:117.

    Full description at Econpapers || Download paper

  49. Drivers of the fatal drug epidemic. (2019). Ruhm, Christopher.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:64:y:2019:i:c:p:25-42.

    Full description at Econpapers || Download paper

  50. Shackling the Identification Police?. (2018). Ruhm, Christopher.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25320.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-09-20 20:16:56 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated August, 3 2024. Contact: Jose Manuel Barrueco.